Patient Registry Study of Berinert® in Normal Clinical Practice
Public ClinicalTrials.gov record NCT01108848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Patient Registry for Berinert®, a C1-Esterase Inhibitor
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this patient registry is to collect data on the safety of Berinert® in normal clinical practice in the United States. The patient registry will be maintained for a period of at least 3 years. The duration of individual patient participation will vary and is determined by the frequency of hereditary angioedema (HAE) attacks and the patient's need for Berinert® treatment.
Study identification
- NCT ID
- NCT01108848
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 318 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2010 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Apr 2014 (Actual)
- Last update posted
- Jun 9, 2014
2010 – 2014
United States locations
- U.S. sites
- 34
- U.S. states
- 20
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| United States, Arizona | Scottsdale | Arizona | 85251 | — |
| United States, California | Granada Hills | California | 91344 | — |
| United States, California | Los Angeles | California | 90095 | — |
| United States, California | Redding | California | 96003 | — |
| United States, California | San Diego | California | 92093 | — |
| United States, Georgia | Atlanta | Georgia | 30342 | — |
| United States, Idaho | Idaho Falls | Idaho | 83404 | — |
| United States, Louisiana | New Orleans | Louisiana | 70118 | — |
| United States, Maryland | Chevy Chase | Maryland | 20815 | — |
| United States, Maryland | Columbia | Maryland | 21044 | — |
| United States, Massachusetts | Boston | Massachusetts | 02115 | — |
| United States, Minnesota | Plymouth | Minnesota | 55446 | — |
| United States, Missouri | Kansas City | Missouri | 64108 | — |
| United States, Missouri | St Louis | Missouri | 63110 | — |
| United States, New Jersey | Branchburg | New Jersey | 08876 | — |
| United States, New Jersey | Edison | New Jersey | 88220 | — |
| United States, New Jersey | Iselin | New Jersey | 08830 | — |
| United States, New Jersey | Ocean City | New Jersey | 07712 | — |
| United States, New York | New York | New York | 10029 | — |
| United States, New York | North Syracuse | New York | 13212 | — |
| United States, North Carolina | Durham | North Carolina | 27710 | — |
| United States, Ohio | Centerville | Ohio | 45458 | — |
| United States, Ohio | Cincinnati | Ohio | 45267 | — |
| United States, Oklahoma | Oklahoma City | Oklahoma | 73131 | — |
| United States, Oklahoma | Tulsa | Oklahoma | 74133 | — |
| United States, Oregon | Lake Oswego | Oregon | 97035 | — |
| United States, Pennsylvania | Altoona | Pennsylvania | 16601 | — |
| United States, Pennsylvania | Hershey | Pennsylvania | 17033 | — |
| United States, Pennsylvania | Pittsburgh | Pennsylvania | 15213 | — |
| United States, South Carolina | Columbia | South Carolina | 29203 | — |
| United States, South Dakota | Rapid City | South Dakota | 57702 | — |
| United States, Texas | Dallas | Texas | 75231 | — |
| United States, Washington | Spokane | Washington | 99204 | — |
| United States, Washington | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01108848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01108848 live on ClinicalTrials.gov.